Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Return on Assets (2021 - 2025)

Historic Return on Assets for Burning Rock Biotech (BNR) over the last 5 years, with Q3 2025 value amounting to 0.13%.

  • Burning Rock Biotech's Return on Assets rose 2900.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year increase of 2900.0%. This contributed to the annual value of 0.34% for FY2024, which is 1400.0% up from last year.
  • Per Burning Rock Biotech's latest filing, its Return on Assets stood at 0.13% for Q3 2025, which was up 2900.0% from 0.15% recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Return on Assets registered a high of 0.13% during Q3 2025, and its lowest value of 0.61% during Q4 2022.
  • For the 5-year period, Burning Rock Biotech's Return on Assets averaged around 0.4%, with its median value being 0.42% (2024).
  • Its Return on Assets has fluctuated over the past 5 years, first crashed by -3700bps in 2022, then surged by 4100bps in 2025.
  • Burning Rock Biotech's Return on Assets (Quarter) stood at 0.24% in 2021, then plummeted by -155bps to 0.61% in 2022, then increased by 2bps to 0.6% in 2023, then surged by 41bps to 0.35% in 2024, then surged by 63bps to 0.13% in 2025.
  • Its last three reported values are 0.13% in Q3 2025, 0.15% for Q2 2025, and 0.26% during Q1 2025.